Evolution
Device Lead Management
PDI 10827002237466
General payments
$352,473
Research payments
$2,000
Through program year 2025, $352,473 in general payments and $2,000 in research payments were reported against Evolution (Lead Management).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $5,235 | 4 |
| 2024 | General | $91,692 | 144 |
| 2023 | General | $76,409 | 153 |
| 2022 | General | $163,618 | 201 |
| 2021 | General | $15,519 | 42 |
| 2021 | Research | $2,000 | 2 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
544 general · 2 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.